Ross Halperin

Kelowna, BC, CA 
Kelowna, BC, CA 

Overview

Ross Halperin practices practicing medicine in Kelowna, Canada.

His clinical expertise encompasses Prostate Cancer, Erectile Dysfunction (ED), and Bone Tumor.

He is actively involved in clinical research, co-authoring 35 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Kelowna, BC, Canada
Other Locations
Vancouver, BC, Canada
Victoria, BC, Canada
Markham, ON L3R9X9, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Partial Breast Irradiation Using Interstitial Permanent Palladium-103 Seed Implant
Partial Breast Irradiation Using Interstitial Permanent Palladium-103 Seed Implant
Enrollment Status: Active_not_recruiting
Publish Date: February 02, 2026
Intervention Type: Device, Radiation
Study Phase: Not Applicable
IMPROVING QUALITY OF LIFE AFTER OPTIMAL RADIOTHERAPY FOR INTERMEDIATE AND HIGH RISK PROSTATE CANCER: A Randomized Comparison of HDR Versus LDR BRACHYTHERAPY BOOST
IMPROVING QUALITY OF LIFE AFTER OPTIMAL RADIOTHERAPY FOR INTERMEDIATE AND HIGH RISK PROSTATE CANCER: A Randomized Comparison of HDR Versus LDR BRACHYTHERAPY BOOST
Enrollment Status: Active_not_recruiting
Publish Date: January 29, 2026
Intervention Type: Radiation
Study Phase: Not Applicable
A Phase III Randomized Study of Low Dose Rate Compared to High Dose Rate Prostate Brachytherapy for Favorable Risk and Low Tier Intermediate Risk Prostate Cancer
A Phase III Randomized Study of Low Dose Rate Compared to High Dose Rate Prostate Brachytherapy for Favorable Risk and Low Tier Intermediate Risk Prostate Cancer
Enrollment Status: Active_not_recruiting
Publish Date: January 29, 2026
Intervention Type: Radiation
Study Phase: Not Applicable
View 2 Less Clinical Trials

35 Total Publications

Ultrahypofractionated Versus Conventionally Fractionated Whole-pelvis Radiotherapy in Prostate Cancer: A Randomized Clinical Trial.
Ultrahypofractionated Versus Conventionally Fractionated Whole-pelvis Radiotherapy in Prostate Cancer: A Randomized Clinical Trial.
Journal: European urology oncology
Published: October 07, 2025

Frequently Asked Questions about Ross Halperin

Is Ross Halperin a top-rated expert for Prostate Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Ross Halperin is classified as an Experienced expert for Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Ross Halperin participate in research or clinical trials?

Yes. Ross Halperin has published 35 articles and abstracts on conditions like Prostate Cancer. You can view a list of Ross Halperin's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Halperin's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile